Loading...
OLED Fab Timing Risks And Blue Emitter Delays Will Eventually Reward Patient Belief
AN
AnalystLowTarget
Not Invested
Community Contributor
Published
28 Jan 26
Views
6
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-41.4%7D
-5.9%1Y
-41.4%7D
-5.9%You can edit this narrative until Jan 29 6:05 PM. Then, changes will post as Updates.
Author's Valuation
US$13030.1% undervalued intrinsic discount
AnalystLowTarget Fair Value